JPS59231018A - 抗脂血剤 - Google Patents

抗脂血剤

Info

Publication number
JPS59231018A
JPS59231018A JP58104691A JP10469183A JPS59231018A JP S59231018 A JPS59231018 A JP S59231018A JP 58104691 A JP58104691 A JP 58104691A JP 10469183 A JP10469183 A JP 10469183A JP S59231018 A JPS59231018 A JP S59231018A
Authority
JP
Japan
Prior art keywords
cholesterol
serum
action
diltiazem
day
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58104691A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6317810B2 (cs
Inventor
Koki Takashima
高島　紘毅
Shuji Nitsuta
仁田　修治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to JP58104691A priority Critical patent/JPS59231018A/ja
Priority to DE19843419425 priority patent/DE3419425A1/de
Priority to NL8401793A priority patent/NL8401793A/nl
Priority to SE8403042A priority patent/SE465352B/sv
Priority to GB08414498A priority patent/GB2141027B/en
Priority to BE0/213101A priority patent/BE899867A/fr
Priority to DK284084A priority patent/DK164021C/da
Priority to FR8409077A priority patent/FR2547730B1/fr
Priority to IT67596/84A priority patent/IT1196710B/it
Priority to CH2838/84A priority patent/CH661867A5/de
Publication of JPS59231018A publication Critical patent/JPS59231018A/ja
Publication of JPS6317810B2 publication Critical patent/JPS6317810B2/ja
Priority to SG210/89A priority patent/SG21089G/en
Priority to HK454/89A priority patent/HK45489A/xx
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
JP58104691A 1983-06-10 1983-06-10 抗脂血剤 Granted JPS59231018A (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤
DE19843419425 DE3419425A1 (de) 1983-06-10 1984-05-24 Verwendung von d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5h)-on als arzneimittel zur bekaempfung der hypolipidaemie
NL8401793A NL8401793A (nl) 1983-06-10 1984-06-05 Hypolipidemisch preparaat.
SE8403042A SE465352B (sv) 1983-06-10 1984-06-06 Anvaendning av diltiazem foer framstaellning av ett laekemedel foer behandling av hyperlipidemi
GB08414498A GB2141027B (en) 1983-06-10 1984-06-07 Diltiazem hypolipidemic compositions
FR8409077A FR2547730B1 (fr) 1983-06-10 1984-06-08 Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
DK284084A DK164021C (da) 1983-06-10 1984-06-08 Anvendelse af diltiazem til fremstilling af et farmaceutisk praeparat til behandling af hyperlipidemi
BE0/213101A BE899867A (fr) 1983-06-10 1984-06-08 Composition antihyperlipidemie a base de diltiazem.
IT67596/84A IT1196710B (it) 1983-06-10 1984-06-08 Composizione ad azione ipolipidemica e suo uso
CH2838/84A CH661867A5 (de) 1983-06-10 1984-06-12 Praeparat zur behandlung von hyperlipidaemie in der human- und veterinaermedizin.
SG210/89A SG21089G (en) 1983-06-10 1989-04-07 Hypolipidemic composition
HK454/89A HK45489A (en) 1983-06-10 1989-06-07 Hypolipidemic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58104691A JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Publications (2)

Publication Number Publication Date
JPS59231018A true JPS59231018A (ja) 1984-12-25
JPS6317810B2 JPS6317810B2 (cs) 1988-04-15

Family

ID=14387491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58104691A Granted JPS59231018A (ja) 1983-06-10 1983-06-10 抗脂血剤

Country Status (12)

Country Link
JP (1) JPS59231018A (cs)
BE (1) BE899867A (cs)
CH (1) CH661867A5 (cs)
DE (1) DE3419425A1 (cs)
DK (1) DK164021C (cs)
FR (1) FR2547730B1 (cs)
GB (1) GB2141027B (cs)
HK (1) HK45489A (cs)
IT (1) IT1196710B (cs)
NL (1) NL8401793A (cs)
SE (1) SE465352B (cs)
SG (1) SG21089G (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood
JPS63107925A (ja) * 1986-05-23 1988-05-12 Tanabe Seiyaku Co Ltd 動脈硬化症予防・治療剤
AT389446B (de) * 1987-10-08 1989-12-11 Tanabe Seiyaku Co Verwendung eines 8-chlorobenzothiazepins zur herstellung eines arzneimittels
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
GB9423172D0 (en) * 1994-11-17 1995-01-04 Wellcom Foundation The Limited Hypolipidemic benzothiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
JPS58208222A (ja) * 1982-05-28 1983-12-03 Japan Found Cancer 抗腫瘍剤効果増強剤
JPS5970611A (ja) * 1982-10-15 1984-04-21 Tanabe Seiyaku Co Ltd 医薬組成物

Also Published As

Publication number Publication date
GB2141027B (en) 1986-10-22
CH661867A5 (de) 1987-08-31
DK164021B (da) 1992-05-04
FR2547730A1 (fr) 1984-12-28
SG21089G (en) 1990-01-26
GB2141027A (en) 1984-12-12
FR2547730B1 (fr) 1987-11-13
SE465352B (sv) 1991-09-02
IT8467596A0 (it) 1984-06-08
DE3419425A1 (de) 1984-12-13
JPS6317810B2 (cs) 1988-04-15
SE8403042D0 (sv) 1984-06-06
NL8401793A (nl) 1985-01-02
DK284084A (da) 1984-12-11
BE899867A (fr) 1984-10-01
DE3419425C2 (cs) 1989-06-08
IT8467596A1 (it) 1985-12-08
HK45489A (en) 1989-06-16
SE8403042L (sv) 1984-12-11
IT1196710B (it) 1988-11-25
GB8414498D0 (en) 1984-07-11
DK164021C (da) 1992-09-28
DK284084D0 (da) 1984-06-08

Similar Documents

Publication Publication Date Title
HU199302B (en) Process for producing synergic pharmaceutical compositions having hypotensive activity
DE60129518T2 (de) Verwendung von einem Vasopressin-Antagonisten wie Conivaptan zur Herstellung eines Medikaments für die Behandlung der pulmonalen Hypertension
CZ299162B6 (cs) Farmaceutický prípravek a souprava
EP0292050B1 (en) Improved flunarizine-containing compositions
US9700565B2 (en) Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias
JPH0733332B2 (ja) 痴呆症状改善・治療剤
RU2367442C2 (ru) Способ нормализации мочеиспускания при нарушении функции почек
TWI225399B (en) Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders
JPS60109523A (ja) 薬理学的活性ケトン化合物
JPS59231018A (ja) 抗脂血剤
US4469690A (en) Synergistic compositions of renal dopaminergic agent and β-blocker
EP0278449B1 (en) Agent having renal function-improving effect and diuretic effect and the use of a benzothiazepin derivative contained therein
KR900006993B1 (ko) 아테롬성 동맥경화증 치료제로서의 dl-5-[(2-벤질-3,4-디하이드로-2H-벤조피란-6-일)메틸]티아졸리딘-2,4-디온
CN1354662A (zh) 奥桑唐特在用于治疗心情疾病的药物制剂中的应用
JPS6317045B2 (cs)
US2799617A (en) Piperazine adipate compositions and treatment of helminth infections therewith
JPH06500129A (ja) ヌクレオシド誘導体
JPS6317044B2 (cs)
JPH11503721A (ja) ベンズアミド誘導体の新規用途
JPH0573729B2 (cs)
US3560617A (en) Pharmaceutical composition containing 3-butylamino - 4 - chloro-5-sulphamylbenzoic acids and salts thereof for the treatment of oedematous conditions and hypertension
EP0273253A2 (de) Verwendung von 6-Allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[5,4-d]azepin zur Freisetzung von Wachstumshormon
JPH0517357A (ja) 血小板減少療法剤
KR930004647B1 (ko) 신장 질환 치료제
JPS6056974A (ja) 環式ジチオジアセトアミドおよびその製造方法並びに薬剤